Obstetrics, Gynecology & Women's Health Institute and Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, and Department of Obstetrics & Gynecology, Duke University, Durham, North Carolina, United States.
Obstetrics, Gynecology & Women's Health Institute and Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, and Department of Obstetrics & Gynecology, Duke University, Durham, North Carolina, United States.
Am J Obstet Gynecol. 2018 Feb;218(2):222.e1-222.e19. doi: 10.1016/j.ajog.2017.10.014. Epub 2017 Oct 19.
Little progress has been made in the prevention of pelvic floor disorders, despite their significant health and economic impact. The identification of women who are at risk remains a key element in targeting prevention and planning health resource allocation strategies. Although events around the time of childbirth are recognized clinically as important predictors, it is difficult to counsel women and to intervene around the time of childbirth because of an inability to convey a patient's risk accurately in the presence of multiple risk factors and the long time lapse, which is often decades, between obstetric events and the onset of pelvic floor disorders later in life. Prediction models and scoring systems have been used in other areas of medicine to identify patients who are at risk for chronic diseases. Models have been developed for use before delivery that predict short-term risk of pelvic floor disorders after childbirth, but no models that predict long-term risk exist.
The purpose of this study was to use variables that are known before and during childbirth to develop and validate prognostic models that will estimate the risks of these disorders 12 and 20 years after delivery.
Obstetric variables were collected from 2 cohorts: (1) women who gave birth in the United Kingdom and New Zealand (n=3763) and (2) women from the Swedish Medical Birth Register (n=4991). Pelvic floor disorders were self-reported 12 years after childbirth in the United Kingdom/New Zealand cohort and 20 years after childbirth in the Swedish Register. The cohorts were split so that data during the first half of the cohort's time period were used to fit prediction models, and validation was performed from the second half (temporal validation). Because there is currently no consensus on how to best define pelvic floor disorders from a patient's perspective, we chose to fit the data for each model using multiple outcome definitions for prolapse, urinary incontinence, fecal incontinence, ≥1 pelvic floor disorder, and ≥2 pelvic floor disorders. Model accuracy was measured in the following manner: (1) by ranking an individual's risk among all subjects in the cohort (discrimination) with the use of a concordance index and (2) by observing whether the predicted probability was too high or low (calibration) at a range of predicted probabilities with the use of visual plots.
Models were able to discriminate between women who experienced bothersome symptoms or received treatment at 12 and 20 years, respectively, for pelvic organ prolapse (concordance indices, 0.570, 0.627), urinary incontinence (concordance indices, 0.653, 0.689), fecal incontinence (concordance indices, 0.618, 0.676), ≥1 pelvic floor disorders (concordance indices, 0.639, 0.675), and ≥2 pelvic floor disorders (concordance indices, 0.635, 0.619). Route of delivery and family history of each pelvic floor disorder were strong predictors in most models. Urinary incontinence before and during the index pregnancy was a strong predictor for the development of all pelvic floor disorders in most models 12 years after delivery. The 12- and 20-year bothersome symptoms or treatment for prolapse models were accurate when predictions were provided for risk from 0% to approximately 15%. The 12- and 20-year primiparous model began to over predict when risk rates reached 20%. When we predicted bothersome symptoms or treatment for urinary incontinence, the 12-year models were accurate when predictions ranged from approximately 5-60%; the 20-year primiparous models were accurate from 5% and 80%. For bothersome symptoms or treatment for fecal incontinence, the 12- and 20-year models were accurate from 1-15% risk and began to over predict at rates at >15% and 20%, respectively.
Models may provide an opportunity before birth to identify women who are at low risk of the development of pelvic floor disorders and may provide institute prevention strategies such as pelvic floor muscle training, weight control, or elective cesarean section for women who are at higher risk. Models are provided at http://riskcalc.org/UR_CHOICE/.
尽管盆腔器官脱垂等疾病对健康和经济造成了重大影响,但在预防方面却鲜有进展。确定患病风险仍然是针对目标人群进行预防和规划卫生资源分配策略的关键要素。尽管分娩前后的事件被临床确认为重要的预测因素,但由于存在多种风险因素,以及从产科事件到后来生活中出现盆底功能障碍的时间间隔往往长达几十年,因此很难准确地向女性提供咨询意见并进行干预。在其他医学领域,预测模型和评分系统已被用于识别患有慢性疾病的患者。已经开发出用于分娩前的模型,可预测产后短期内发生盆底功能障碍的风险,但不存在预测长期风险的模型。
本研究旨在利用分娩前后已知的变量,开发和验证预后模型,以估计产后 12 年和 20 年发生这些疾病的风险。
从两个队列中收集了产科变量:(1)在英国和新西兰分娩的妇女(n=3763)和(2)来自瑞典医疗出生登记处的妇女(n=4991)。在英国/新西兰队列中,产后 12 年和瑞典登记处中,产后 20 年报告了盆底功能障碍。将队列分开,以便在队列的前半段时间内使用数据拟合预测模型,在后半段时间(时间验证)进行验证。由于目前对于从患者的角度如何最好地定义盆底功能障碍尚无共识,因此我们选择使用脱垂、尿失禁、粪失禁、≥1 种盆底功能障碍和≥2 种盆底功能障碍的多种结果定义拟合每个模型的数据。通过以下方式衡量模型准确性:(1)使用一致性指数对队列中所有受试者的个体风险进行排序(区分度);(2)通过观察在一系列预测概率下预测概率过高或过低的情况(校准),使用视觉图进行观察。
对于盆腔器官脱垂(一致性指数,0.570,0.627)、尿失禁(一致性指数,0.653,0.689)、粪失禁(一致性指数,0.618,0.676)、≥1 种盆底功能障碍(一致性指数,0.639,0.675)和≥2 种盆底功能障碍(一致性指数,0.635,0.619),模型能够区分分别在产后 12 年和 20 年经历有症状或接受治疗的女性。分娩方式和每种盆底功能障碍的家族史是大多数模型中的强有力预测因素。在产后 12 年,指数妊娠前和期间的尿失禁是大多数模型中所有盆底功能障碍发展的强有力预测因素。在预测风险从 0%到大约 15%时,12 年和 20 年有症状或治疗脱垂的模型是准确的。当风险率达到 20%时,12 年和 20 年初产妇模型开始过度预测。当我们预测尿失禁的有症状或治疗时,12 年模型在预测范围为 5%-60%时是准确的;20 年初产妇模型在 5%和 80%时是准确的。对于粪失禁的有症状或治疗,12 年和 20 年模型在 1%-15%的风险时是准确的,并且分别在>15%和 20%时开始过度预测。
模型可能为女性在分娩前提供一个机会,以确定低风险发生盆底功能障碍的女性,并可能为高风险女性提供盆底肌肉训练、体重控制或选择性剖宫产等预防策略。模型可在 http://riskcalc.org/UR_CHOICE/ 上获得。